Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Intestinal Research|October 11, 2018
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in IndiaAshish Agarwal, Saurabh Kedia, Saransh Jain, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 14, 2019
Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel diseaseSanjeevani K Tomar, Saurabh Kedia, Namrata Singh, et al.
Digestive Diseases and Sciences|June 13, 2019
Percutaneous Endoscopic Step-Up Therapy Is an Effective Minimally Invasive Approach for Infected Necrotizing PancreatitisSaransh Jain, Rajesh Padhan, Sawan Bopanna, et al.
Journal of Crohn'S & Colitis|November 1, 2017
Faecal Calprotectin and UCEIS Predict Short-term Outcomes in Acute Severe Colitis: Prospective Cohort StudySaransh Jain, Saurabh Kedia, Sawan Bopanna, et al.
Inflammatory Bowel Diseases|May 30, 2020
Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNγ ProductionRitika Rampal, Nahidul Wari, Amit Kumar Singh, et al.
Intestinal Research|May 20, 2017
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysisSaurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, et al.
Intestinal Research|February 10, 2018
Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective studySaransh Jain, Saurabh Kedia, Sawan Bopanna, et al.
United European Gastroenterology Journal|August 18, 2017
Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel diseaseSawan Bopanna, Saurabh Kedia, Prasenjit Das, et al.
Scientific Reports|December 24, 2017
Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant roleSandeep Goyal, Ritika Rampal, Saurabh Kedia, et al.
Digestive Diseases and Sciences|June 28, 2018
Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe DiseaseSaurabh Kedia, Saransh Jain, Sandeep Goyal, et al.
Pageof 5